PEITC for Health & Longevity

Created on 11/06/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Phenethyl isothiocyanate, a plant compound in watercress, draws interest for cancer prevention and longevity. Small human studies show it changes how the body handles certain toxins; whether this lowers cancer rates or extends healthy life has never been tested. Side effects are mostly mild stomach and mouth irritation; it can alter how some medications are handled. Evidence supports it as a plausible, low-cost add-on through food, of uncertain long-term value. (Full Review)

Protocol

Purified PEITC (research protocol)
40 mg/day
10 mg in 1 mL olive oil four times daily, for 1 week, in smokers
Raw watercress
56.8 g at each of three meals
About 19–38 mg PEITC daily
Time of day
With meals
Common practice; PEITC is fat-soluble and irritant on an empty stomach
Time to effect
Oral cancer outcomes
1 and 3 months
Assessment points in the advanced oral cancer trial
Carcinogen-metabolite changes
2–3 days
Seen with watercress in smokers
DNA damage in blood cells
8 weeks
Lower DNA strand breaks with 85 g raw watercress daily

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Bladder cancer or precancerous bladder lesions
  • Users of narrow-margin CYP2C9 drugs (warfarin, phenytoin) for purified high-dose PEITC
  • Known allergy to mustard, horseradish or wasabi isothiocyanates
Key Interactions
  • CYP2E1 substrates (chlorzoxazone, enflurane)
  • Acetaminophen (paracetamol)
  • Nicotine (cigarettes, nicotine replacement)
  • CYP1A2 substrates (caffeine, theophylline, clozapine)
Theoretical (inferred from mechanism)
  • CYP2C9 and CYP2B6 substrates (warfarin; bupropion)
  • CYP2C19 and CYP3A4 substrates (clopidogrel; simvastatin)
  • Chemotherapy relying on oxidative stress (doxorubicin, cisplatin)
  • Other Nrf2-activating supplements (sulforaphane, curcumin)
  • Thiol antioxidants (N-acetylcysteine, glutathione)
  • BCRP and MRP transporter substrates (methotrexate, rosuvastatin)

Risk & Side Effects

  • High: Gastrointestinal and oral irritation
  • Medium:
  • Low: Altered metabolism of co-administered drugs
  • Speculative: Bladder tumor promotion at high intakes; protection of established tumors; thyroid disruption

Monitoring

Marker Target Why
ALT and AST ALT 7–55 U/L; AST 8–48 U/L Liver safety check
Urinalysis for blood Negative for blood Bladder safety check
INR (warfarin users only) No established target for PEITC; track change from the individual's stable baseline Safety check for warfarin dosing
Urinary PEITC-NAC No established target; track change from the individual's own baseline Confirms intake and absorption

Cadence: Baseline before purified PEITC; liver enzymes at 4–8 weeks, then every 6–12 months during continued purified use; urinalysis every 6–12 months; INR within 1–2 weeks of starting or changing dose for warfarin users. Watercress eaten as food in normal amounts needs no special testing.

Qualitative Assessment

  • Gastrointestinal comfort (nausea, abdominal pain, belching, diarrhea)
  • Mouth sensations (burning, dryness, altered taste)
  • Energy and general well-being
  • Adherence to the planned dose and schedule